Sense Biodetection Limited is a molecular diagnostics company .
Sense Biodetection has raised €27M across 2 funding rounds from 1 investor, most recently a Series B round in Nov 2021. Based in Abingdon, UK; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-11-18 | Series B | €13M | Koch Disruptive Technologies | View deal → |
| 2019-10-01 | Other | €14M | — | View deal → |
